Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) Return on Equity (2016 - 2025)

Historic Return on Equity for Utah Medical Products (UTMD) over the last 15 years, with Q3 2025 value amounting to 0.1%.

  • Utah Medical Products' Return on Equity fell 200.0% to 0.1% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.1%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.11% for FY2024, which is 200.0% down from last year.
  • As of Q3 2025, Utah Medical Products' Return on Equity stood at 0.1%, which was down 200.0% from 0.11% recorded in Q2 2025.
  • In the past 5 years, Utah Medical Products' Return on Equity registered a high of 0.15% during Q3 2022, and its lowest value of 0.1% during Q3 2025.
  • Its 5-year average for Return on Equity is 0.13%, with a median of 0.13% in 2024.
  • As far as peak fluctuations go, Utah Medical Products' Return on Equity plummeted by -500bps in 2021, and later soared by 400bps in 2022.
  • Quarter analysis of 5 years shows Utah Medical Products' Return on Equity stood at 0.14% in 2021, then increased by 6bps to 0.14% in 2022, then decreased by -8bps to 0.13% in 2023, then dropped by -13bps to 0.11% in 2024, then dropped by -14bps to 0.1% in 2025.
  • Its Return on Equity was 0.1% in Q3 2025, compared to 0.11% in Q2 2025 and 0.11% in Q1 2025.